Lazard Asset Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$90.2K Buy
+1,369
New +$87K ﹤0.01% 1735
2025
Q3
Sell
-2,055
Closed -$67K 1927
2025
Q2
$67K Sell
2,055
-34,113
-94% -$1.19M ﹤0.01% 1956
2025
Q1
$1.45M Buy
+36,168
New +$1.66M ﹤0.01% 1069
2023
Q3
Sell
-24,716
Closed -$806K 2314
2023
Q2
$806K Sell
24,716
-10,292
-29% -$381K ﹤0.01% 1028
2023
Q1
$1.23M Sell
35,008
-4,120
-11% -$168K ﹤0.01% 987
2022
Q4
$1.79M Sell
39,128
-12,017
-23% -$517K ﹤0.01% 918
2022
Q3
$2.48M Sell
51,145
-1,648,281
-97% -$79.3M ﹤0.01% 843
2022
Q2
$66.8M Buy
1,699,426
+1,697,631
+94,576% +$68.3M 0.09% 196
2022
Q1
$66K Buy
1,795
+1,695
+1,695% +$60.2K ﹤0.01% 1599
2021
Q4
$4K Hold
100
﹤0.01% 2178
2021
Q3
$3K Buy
+100
New +$2.94K ﹤0.01% 2107
2021
Q2
Sell
-114,478
Closed -$2.66M 1981
2021
Q1
$2.66M Sell
114,478
-28,921
-20% -$618K ﹤0.01% 754
2020
Q4
$2.98M Sell
143,399
-118,115
-45% -$2.16M ﹤0.01% 726
2020
Q3
$5.66M Sell
261,514
-8,076
-3% -$189K 0.01% 587
2020
Q2
$6.35M Buy
+269,590
New +$5.06M 0.01% 533

Other funds holding CYTK